Literature DB >> 18775714

MEN1 missense mutations impair sensitization to apoptosis induced by wild-type menin in endocrine pancreatic tumor cells.

Wissam Bazzi1, Maud Renon, Cécile Vercherat, Zeinab Hamze, Annie Lacheretz-Bernigaud, Hayian Wang, Martine Blanc, Colette Roche, Alain Calender, Jean-Alain Chayvialle, Jean-Yves Scoazec, Martine Cordier-Bussat.   

Abstract

BACKGROUND & AIMS: Missense mutations account for 30% of mutations identified in patients with the multiple endocrine neoplasia type 1 (MEN1) syndrome. They raise several issues: the distinction between pathogenic mutations and polymorphisms is sometimes difficult and the functional effects of missense mutations are unclear. We aimed to evaluate the functional consequences of missense MEN1 mutations in an appropriate endocrine cellular context.
METHODS: From the INS-1 insulinoma cell line, we established clones conditionally over expressing wild-type (WT) menin or its A160T, H317Y, and A541T variants. We compared the consequences of WT or variant menin over expression on apoptotic response after gamma-irradiation and analyzed the interactions of these proteins with p53.
RESULTS: WT menin over expression sensitized INS-r3 cells to apoptosis through amplification of caspase-3 activation, increased p53 acetylation, and accelerated p21 activation; moreover, over expressed WT menin could be recovered in p53-containing complexes. For all 3 missense mutations tested, the functional effects observed with WT were impaired significantly and only low amounts of variant menin proteins were recovered in p53-containing complexes.
CONCLUSIONS: Taking advantage of a new endocrine cellular model, we show a loss of function for 2 missense disease-related menin mutants and for a controversial variant as well. Furthermore, our results suggest the existence of functional interactions between p53 and menin for the control of apoptosis, which may cast new light on the mechanisms of endocrine tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18775714     DOI: 10.1053/j.gastro.2008.07.031

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  17 in total

1.  Primary aldosteronism complicated by hyperparathyroidism: report of one case and literature review.

Authors:  Dandan Zhou; Min Liu; Zhaoli Yan
Journal:  Int J Clin Exp Pathol       Date:  2019-08-01

2.  Expression of lysophosphatidic acid receptors and local invasiveness and metastasis in Chinese pancreatic cancers.

Authors:  Y L Gong; C J Tao; M Hu; J F Chen; X F Cao; G M Lv; P Li
Journal:  Curr Oncol       Date:  2012-07       Impact factor: 3.677

3.  Altered MENIN expression disrupts the MAFA differentiation pathway in insulinoma.

Authors:  Z Hamze; C Vercherat; A Bernigaud-Lacheretz; W Bazzi; R Bonnavion; J Lu; A Calender; C Pouponnot; P Bertolino; C Roche; R Stein; J Y Scoazec; C X Zhang; M Cordier-Bussat
Journal:  Endocr Relat Cancer       Date:  2013-10-24       Impact factor: 5.678

4.  Loss of p27 expression is associated with MEN1 gene mutations in sporadic parathyroid adenomas.

Authors:  Simona Borsari; Elena Pardi; Natalia S Pellegata; Misu Lee; Federica Saponaro; Liborio Torregrossa; Fulvio Basolo; Elena Paltrinieri; Maria Chiara Zatelli; Gabriele Materazzi; Paolo Miccoli; Claudio Marcocci; Filomena Cetani
Journal:  Endocrine       Date:  2016-04-02       Impact factor: 3.633

Review 5.  Genetic and epigenetic mutations of tumor suppressive genes in sporadic pituitary adenoma.

Authors:  Yunli Zhou; Xun Zhang; Anne Klibanski
Journal:  Mol Cell Endocrinol       Date:  2013-09-11       Impact factor: 4.102

6.  Proliferation rates of multiple endocrine neoplasia type 1 (MEN1)-associated tumors.

Authors:  Gerard V Walls; Anita A C Reed; Jeshmi Jeyabalan; Mahsa Javid; Nathan R Hill; Brian Harding; Rajesh V Thakker
Journal:  Endocrinology       Date:  2012-09-28       Impact factor: 4.736

7.  Alterations of MEN1 and E-cadherin/β-catenin complex in sporadic pulmonary carcinoids.

Authors:  Serena Veschi; Rossano Lattanzio; Gitana Maria Aceto; Maria Cristina Curia; Salvatore Magnasco; Domenico Angelucci; Alessandro Cama; Mauro Piantelli; Pasquale Battista
Journal:  Int J Oncol       Date:  2012-07-20       Impact factor: 5.650

8.  The menin tumor suppressor protein is phosphorylated in response to DNA damage.

Authors:  Joshua Francis; Wenchu Lin; Orit Rozenblatt-Rosen; Matthew Meyerson
Journal:  PLoS One       Date:  2011-01-14       Impact factor: 3.240

Review 9.  Variable clinical expression in patients with a germline MEN1 disease gene mutation: clues to a genotype-phenotype correlation.

Authors:  Cornelis J Lips; Koen M Dreijerink; Jo W Höppener
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

10.  Novel MEN 1 gene findings in rare sporadic insulinoma--a case control study.

Authors:  Viveka P Jyotsna; Ekta Malik; Shweta Birla; Arundhati Sharma
Journal:  BMC Endocr Disord       Date:  2015-08-26       Impact factor: 2.763

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.